Implantable hyaluronic acid-deferoxamine conjugate prevents nonunions through stimulation of neovascularization

Approximately 6.3 million fractures occur in the U.S. annually, with 5–10% resulting in debilitating nonunions. A major limitation to achieving successful bony union is impaired neovascularization. To augment fracture healing, we designed an implantable drug delivery technology containing the angiog...

Descripción completa

Detalles Bibliográficos
Autores principales: Donneys, Alexis, Yang, Qiuhong, Forrest, Marcus Laird, Nelson, Noah S., Zhang, Ti, Ettinger, Russell, Ranganathan, Kavitha, Snider, Alicia, Deshpande, Sagar S., Cohen, Mark S., Buchman, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529413/
https://www.ncbi.nlm.nih.gov/pubmed/31123600
http://dx.doi.org/10.1038/s41536-019-0072-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529413/
https://www.ncbi.nlm.nih.gov/pubmed/31123600
http://dx.doi.org/10.1038/s41536-019-0072-9

Ejemplares similares